English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

N 6 -methyladenosine (m 6 A), the most prevalent chemical modification found on eukaryotic mRNA, is associated with almost all stages of mRNA metabolism and influences various human diseases. Recent research has implicated the aberrant regulation of m 6 A mRNA modification in many human cancers. An increasing number of studies have revealed that dysregulation of m 6 A-containing gene expression via the abnormal expression of m 6 A methyltransferases, demethylases, or reader proteins is closely associated with tumorigenicity. Notably, the molecular functions and cellular consequences of m 6 A mRNA modification often show opposite results depending on the degree of m 6 A modification in specific mRNA. In this review, we highlight the current progress on the underlying mechanisms of m 6 A modification in mRNA metabolism, particularly the functions of m 6 A writers, erasers, and readers in the context of tumorigenesis.

Diverse molecular functions of m6A mRNA modification in cancer